Skip to main content

Peer Review reports

From: Efficacy and safety of pomalidomide and low-dose dexamethasone in Chinese patients with relapsed or refractory multiple myeloma: a multicenter, prospective, single-arm, phase 2 trial

Original Submission
16 Dec 2021 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
Resubmission - Version 3
Submitted Manuscript version 3
14 Apr 2022 Reviewed Reviewer Report
4 May 2022 Reviewed Reviewer Report - Ghulam Rehman Mohyuddin
20 May 2022 Author responded Author comments - Jin Lu
Resubmission - Version 4
20 May 2022 Submitted Manuscript version 4
26 May 2022 Author responded Author comments - Jin Lu
Resubmission - Version 5
26 May 2022 Submitted Manuscript version 5
2 Jun 2022 Author responded Author comments - Jin Lu
Resubmission - Version 6
2 Jun 2022 Submitted Manuscript version 6
7 Jun 2022 Reviewed Reviewer Report
12 Jun 2022 Reviewed Reviewer Report - Ghulam Rehman Mohyuddin
Resubmission - Version 7
Submitted Manuscript version 7
Publishing
16 Jun 2022 Editorially accepted
1 Jul 2022 Article published 10.1186/s12885-022-09802-y

You can find further information about peer review here.

Back to article page